1,2,4-Triazole-3,5-diamine derivatives
US4318913A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Apr 26, 1979 |
| Grant date | Mar 9, 1982 |
| Priority date | — |
| Expiry date | Apr 26, 1999 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D317/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention relates to compounds of the formula (I) ##STR1## and physiologically acceptable salts, hydrates and bioprecursors thereof, in which PA1 R.sub.1 and R.sub.2 represent hydrogen, an aliphatic or cycloaliphatic group, or R.sub.1 and R.sub.2 together with the nitrogen atom form a 5 to 10 membered heterocyclic ring: PA1 Alk represents a straight or branched alkylene chain; PA1 Q represents furan, thiophen or benzene ring which is incorporated into the rest of the molecule; PA1 X represents --CH.sub.2 --, ##STR2## --O-- or --S-- where PA1 R.sub.6 represents hydrogen or methyl; PA1 n represents zero, 1 or 2; PA1 m represents 2, 3 or 4; PA1 R.sub.3 represents hydrogen, a substituted or unsubstituted aliphatic or aryl group and; PA1 R.sub.4 and R.sub.5, which may be the same or different, each represent hydrogen, a substituted or unsubstituted aliphatic, aryl, or together with the nitrogen atom form a heterocyclic group.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.